AVI BioPharma Inc. (AVII) Profile

Profile for AVI BioPharma Inc. (AVII)

After Hours: $ 1.08

-0.03 (-2.70%)

Volume: 900

4:00 PM EST Feb 10, 2012


Business Description: AVI BioPharma, Inc. is focused on the discovery and development of novel RNA-based therapeutics for rare and infectious diseases, as well as other select disease targets.

Address:	3450 Monte Villa Parkway, Suite 101, Bothell, WA, 98021
Telephone:	(425) 354-5038	Website:	www.avibio.com
Facsimile:	N/A	Email:	investorrelations@avibio.com


Details

CEO:	Mr. Christopher Garabedian
Employees:	98	Market Cap:	150.67 m
Issue Type:	CS
Auditor:	KPMG LLP
Last Audit:	Unqualified
Indices:	Biotechnology


Industry Classifications

Sector:	Healthcare	CIK:	0000873303
Industry:	Drugs
Sub-Industry:	Biotechnology
NAICS:	Pharmaceutical Preparation Manufacturing (325412)
SIC:	Pharmaceutical Preparations (2834)

Tags for AVI BioPharma Inc.

Research stocks or mutual funds related to AVI BioPharma Inc. by keywords or tags. Find companies that have a similar focus to AVII. The keywords below have been associated to AVII by either user submission or electronic means.

healthcare jobs biotech research clinical trial logistics jobs in memphis fashion employment corporate governance quotient clinical research trial biopharma clinical research software biotech news biotechnology industry news clinical trials data pharmaceutical validation medical device register biotechnology news corporate governance blog pharmaceutical market corporate governance consulting corporate governance training generic pharmaceutical global medical tourism jobs gene pressler clinical diagnostics clinical pharmacology medical devices market medical device pr clinical research consulting gene pitney medical product development bookkeeping jobs nursing jobs medical device sales securities attorney pharmaceutical research and development corporate governance legislation annual report corporate governance committee charter attorney jobs attorney jobs in texas medical device contract manufacturing investment shares corporate governance calpers corporate governance gene tierney pharma manufacturing pharmaceutical clinical research corporate governance practices identity audit pfizer pharmaceutical company

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.